Related Experiment Video

Updated: Aug 11, 2026

Visualization of Amyloid β Deposits in the Human Brain with Matrix-assisted Laser Desorption/Ionization Imaging Mass Spectrometry
09:31

Visualization of Amyloid β Deposits in the Human Brain with Matrix-assisted Laser Desorption/Ionization Imaging Mass Spectrometry

Published on: March 7, 2019

Abeta-2M-amyloidosis and related bone diseases

Junichiro James Kazama1, Suguru Yamamoto, Naoki Takahashi

  • 1Division of Clinical Nephrology and Rheumatology, Niigata University Graduate School of Medical and Dental Sciences, 1-754 Asahimachi-dori, Niigata, 951-8510, Japan. jjkaz@med.niigata-u.ac.jp

Journal of Bone and Mineral Metabolism
|February 28, 2006
PubMed

Insights

Beta2-microglobulin amyloidosis (Abeta-2M) is linked to chronic kidney disease. Research is ongoing to understand its mechanisms and develop treatments for this dialysis complication.

Area of Science:

  • Nephrology
  • Rheumatology
  • Biochemistry

Background:

  • Beta2-microglobulin amyloidosis (Abeta-2M) is a systemic complication associated with chronic kidney disease and kidney failure.
  • Elevated serum beta2-microglobulin is the primary driver of Abeta-2M amyloid fibril formation.
  • The exact molecular mechanisms underlying Abeta-2M amyloidogenesis are not fully understood.

Purpose of the Study:

  • To investigate the in vitro mechanisms of Abeta-2M amyloidogenesis.
  • To explore the cellular basis of osteolytic lesions associated with Abeta-2M deposition.
  • To identify potential therapeutic targets for Abeta-2M amyloidosis.

Main Methods:

  • In vitro studies analyzing Abeta-2M amyloidogenesis.
  • Histopathological examination of osteolytic lesions in synovial membranes.
  • Cellular analysis of osteoclastogenesis and osteoblastic activity.

Main Results:

  • In vitro studies on Abeta-2M amyloidogenesis are actively being pursued.
  • Osteolytic lesions with Abeta-2M deposition show significant osteoclast activity and absent osteoblastic bone formation.
  • Inflammation, potentially mediated by macrophages/monocytes, is implicated in the observed bone resorption.

Conclusions:

  • The precise mechanisms of Abeta-2M amyloidogenesis and associated inflammation require further elucidation.
  • Understanding these processes is crucial for developing effective treatments for patients undergoing long-term dialysis.
  • Targeting inflammatory pathways may offer a therapeutic strategy for Abeta-2M-related bone disease.

More Related Videos

Murine Hind Limb Long Bone Dissection and Bone Marrow Isolation07:17

Murine Hind Limb Long Bone Dissection and Bone Marrow Isolation

Published on: April 14, 2016

Rapid Generation of Amyloid from Native Proteins In vitro05:48

Rapid Generation of Amyloid from Native Proteins In vitro

Published on: December 5, 2013

Related Concept Videos

Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining, normally used to...
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Bone Disorders01:29

Bone Disorders

Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...